$PFE Recent Headlines
AstraZeneca lifts 2014 guidance as profit slides 2:33 a.m. Nov. 6, 2014 - MarketWatch.com
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
5 ways to profit from sex (without having it) 1:24 p.m. Oct. 28, 2014 - Charles Passy
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
Newscast: Feds kick off two-day meeting 7:37 a.m. Oct. 28, 2014 - MarketWatch
Pfizer sales fall less than expected 7:34 a.m. Oct. 28, 2014 - MarketWatch.com
Pfizer's stock rallies after earnings, sales beat expectations 7:16 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer's stock rises 1.8% premarket after Q3 results 7:04 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer revises 2014 sales outlook to $48.7 bln-$49.7 bln from $48.7 bln-$50.7 bln 7:03 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer revises 2014 EPS outlook to $2.23-$2.27 from $2.20-$2.30 7:02 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 sales tops FactSet consensus $12.28 bln 7:02 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 sales $12.36 bln vs. $12.64 bln a year ago 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 net EPS 42 cents vs. 39 cents a year ago 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 adj. EPS 57 cents vs. FactSet consensus 55 cents 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
What to look for in Pfizer earnings 4:44 p.m. Oct. 27, 2014 - Jonathan D. Rockoff
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
Pfizer ends agreement to develop Remoxy 9:05 a.m. Oct. 27, 2014 - Tess Stynes
Pain Therapeutics, Durect shares tumble after Pfizer discontinues development pact 8:46 a.m. Oct. 27, 2014 - Tomi Kilgore
Energy, health care earnings to dominate week 5:02 a.m. Oct. 26, 2014 - Wallace Witkowski
Money for Nothing 4:36 a.m. Nov. 8, 2014 - Barrons.com
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Tracking Kahn Brothers Portfolio - Q3 2014 Update 2:17 a.m. Nov. 7, 2014 - Seeking Alpha
Will Pfizer Sweeten Its Bid For AstraZeneca? 5:41 p.m. Nov. 6, 2014 - Investors Business Daily
10-Q: PFIZER INC 5:07 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Move Over Federal Reserve, There's a New Central Bank in Town 2:35 p.m. Nov. 6, 2014 - TheStreet.com
CEO-Less Sanofi Tries to Regain Mojo 1:50 p.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Needs to Account for Next Year’s Challenges 10:34 a.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
Divided Government Won't Halt Wall Street's Run 9:58 a.m. Nov. 6, 2014 - FOXBusiness
AstraZeneca Profit Outlook Improves 7:39 a.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
Biosimilars: The Good, the Bad and the Unknown 7:27 a.m. Nov. 6, 2014 - Barrons.com
Monotype Gets Its Font Tech Deeper Into Advertising 5:26 p.m. Nov. 5, 2014 - Investors Business Daily
Warburg Pincus-Owned GT Nexus Explores Sale 2:28 p.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
VRX, CELG And PFE, Pushing Drugs Industry Downward 2:13 p.m. Nov. 4, 2014 - TheStreet.com
Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog 12:50 p.m. Nov. 4, 2014 - Zacks.com
"Goodbye Mr. Jones": The End Of The Dow As An American Index 10:12 a.m. Nov. 4, 2014 - Seeking Alpha
Zoetis Rides Livestock as Results Top Expectations 9:17 a.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Is Attractive Even Without Pfizer Bid 8:19 a.m. Nov. 4, 2014 - Seeking Alpha
Minerals Technologies Digs Up A Winner With Buyout 12:47 p.m. Nov. 3, 2014 - Investors Business Daily
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides 12:21 p.m. Nov. 3, 2014 - Seeking Alpha
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference 11:00 a.m. Nov. 5, 2014 - BusinessWire - BZX
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults 2:44 p.m. Oct. 29, 2014 - BusinessWire - BZX
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder 8:30 a.m. Oct. 29, 2014 - BusinessWire - BZX
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 9:22 a.m. Oct. 28, 2014 - ACCESSWIRE
DURECT Provides Update on REMOXY® and POSIDUR™ Programs 8:05 a.m. Oct. 27, 2014 - PR Newswire - PRF
Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII 8:02 a.m. Oct. 27, 2014 - BusinessWire - BZX
Pain Therapeutics to Regain Full Rights to REMOXY(R) 8:01 a.m. Oct. 27, 2014 - GlobeNewswire
Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend 4:08 p.m. Oct. 23, 2014 - BusinessWire - BZX
Pfizer Wins SUTENT® Patent Case In Delaware District Court 8:05 a.m. Oct. 23, 2014 - BusinessWire - BZX
ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review 11:59 a.m. Oct. 13, 2014 - BusinessWire - BZX
Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis 8:55 a.m. Oct. 10, 2014 - PR Newswire - PRF
Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™ 8:00 a.m. Oct. 10, 2014 - BusinessWire - BZX
Top 10 Health Care Trends Report Finds Opportunities to Achieve "Triple Aim" 2:45 p.m. Oct. 9, 2014 - PR Newswire - PRF
Kane Biotech Appoints Mark Nawacki to the Board of Directors 8:06 a.m. Oct. 8, 2014 - Marketwired
Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine 8:01 a.m. Oct. 8, 2014 - BusinessWire - BZX
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Oct. 1, 2014 - GlobeNewswire
AstraZeneca lifts 2014 guidance as profit slides 2:33 a.m. Nov. 6, 2014 - MarketWatch.com
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
5 ways to profit from sex (without having it) 1:24 p.m. Oct. 28, 2014 - Charles Passy
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
Newscast: Feds kick off two-day meeting 7:37 a.m. Oct. 28, 2014 - MarketWatch
Pfizer sales fall less than expected 7:34 a.m. Oct. 28, 2014 - MarketWatch.com
Pfizer's stock rallies after earnings, sales beat expectations 7:16 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer's stock rises 1.8% premarket after Q3 results 7:04 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer revises 2014 sales outlook to $48.7 bln-$49.7 bln from $48.7 bln-$50.7 bln 7:03 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer revises 2014 EPS outlook to $2.23-$2.27 from $2.20-$2.30 7:02 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 sales tops FactSet consensus $12.28 bln 7:02 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 sales $12.36 bln vs. $12.64 bln a year ago 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 net EPS 42 cents vs. 39 cents a year ago 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
Pfizer Q3 adj. EPS 57 cents vs. FactSet consensus 55 cents 7:01 a.m. Oct. 28, 2014 - Tomi Kilgore
What to look for in Pfizer earnings 4:44 p.m. Oct. 27, 2014 - Jonathan D. Rockoff
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
Pfizer ends agreement to develop Remoxy 9:05 a.m. Oct. 27, 2014 - Tess Stynes
Pain Therapeutics, Durect shares tumble after Pfizer discontinues development pact 8:46 a.m. Oct. 27, 2014 - Tomi Kilgore
Energy, health care earnings to dominate week 5:02 a.m. Oct. 26, 2014 - Wallace Witkowski
Money for Nothing 4:36 a.m. Nov. 8, 2014 - Barrons.com
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Tracking Kahn Brothers Portfolio - Q3 2014 Update 2:17 a.m. Nov. 7, 2014 - Seeking Alpha
Will Pfizer Sweeten Its Bid For AstraZeneca? 5:41 p.m. Nov. 6, 2014 - Investors Business Daily
10-Q: PFIZER INC 5:07 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Move Over Federal Reserve, There's a New Central Bank in Town 2:35 p.m. Nov. 6, 2014 - TheStreet.com
CEO-Less Sanofi Tries to Regain Mojo 1:50 p.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Needs to Account for Next Year’s Challenges 10:34 a.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
Divided Government Won't Halt Wall Street's Run 9:58 a.m. Nov. 6, 2014 - FOXBusiness
AstraZeneca Profit Outlook Improves 7:39 a.m. Nov. 6, 2014 - The Wall Street Journal Interactive Edition
Biosimilars: The Good, the Bad and the Unknown 7:27 a.m. Nov. 6, 2014 - Barrons.com
Monotype Gets Its Font Tech Deeper Into Advertising 5:26 p.m. Nov. 5, 2014 - Investors Business Daily
Warburg Pincus-Owned GT Nexus Explores Sale 2:28 p.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
VRX, CELG And PFE, Pushing Drugs Industry Downward 2:13 p.m. Nov. 4, 2014 - TheStreet.com
Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog 12:50 p.m. Nov. 4, 2014 - Zacks.com
"Goodbye Mr. Jones": The End Of The Dow As An American Index 10:12 a.m. Nov. 4, 2014 - Seeking Alpha
Zoetis Rides Livestock as Results Top Expectations 9:17 a.m. Nov. 4, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Is Attractive Even Without Pfizer Bid 8:19 a.m. Nov. 4, 2014 - Seeking Alpha
Minerals Technologies Digs Up A Winner With Buyout 12:47 p.m. Nov. 3, 2014 - Investors Business Daily
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides 12:21 p.m. Nov. 3, 2014 - Seeking Alpha
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference 11:00 a.m. Nov. 5, 2014 - BusinessWire - BZX
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults 2:44 p.m. Oct. 29, 2014 - BusinessWire - BZX
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder 8:30 a.m. Oct. 29, 2014 - BusinessWire - BZX
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 9:22 a.m. Oct. 28, 2014 - ACCESSWIRE
DURECT Provides Update on REMOXY® and POSIDUR™ Programs 8:05 a.m. Oct. 27, 2014 - PR Newswire - PRF
Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII 8:02 a.m. Oct. 27, 2014 - BusinessWire - BZX
Pain Therapeutics to Regain Full Rights to REMOXY(R) 8:01 a.m. Oct. 27, 2014 - GlobeNewswire
Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend 4:08 p.m. Oct. 23, 2014 - BusinessWire - BZX
Pfizer Wins SUTENT® Patent Case In Delaware District Court 8:05 a.m. Oct. 23, 2014 - BusinessWire - BZX
ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review 11:59 a.m. Oct. 13, 2014 - BusinessWire - BZX
Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis 8:55 a.m. Oct. 10, 2014 - PR Newswire - PRF
Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™ 8:00 a.m. Oct. 10, 2014 - BusinessWire - BZX
Top 10 Health Care Trends Report Finds Opportunities to Achieve "Triple Aim" 2:45 p.m. Oct. 9, 2014 - PR Newswire - PRF
Kane Biotech Appoints Mark Nawacki to the Board of Directors 8:06 a.m. Oct. 8, 2014 - Marketwired
Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine 8:01 a.m. Oct. 8, 2014 - BusinessWire - BZX
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance 8:00 a.m. Oct. 1, 2014 - GlobeNewswire
